{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T19:27:14Z","timestamp":1791487634306,"version":"4.3.4"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T00:00:00Z","timestamp":1658793600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Narodowe Ce","award":["2017\/25\/B\/NZ3\/00122"],"award-info":[{"award-number":["2017\/25\/B\/NZ3\/00122"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ovarian Res"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Clinical outcomes of cancer cell senescence are still elusive. Here, we reveal and compare pro-cancerous activity of spontaneously and drug-inducible senescent ovarian cancer cells. Experiments were performed on tumors and tumor-derived primary epithelial ovarian cancer cells (pEOCs) that were obtained from chemotherapy-na\u00efve patients and from patients who received carboplatin (CPT) and paclitaxel (PCT) before cytoreduction.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The analysis of tumors showed that senescent cancer cells are present in patients from both groups, albeit most frequently and covering a greater area in tissues from chemotherapy-positive women. This in vivo senescence of pEOCs translated to an expression of senescence markers in early-passage cells in vitro. A conditioned medium from senescent pEOCs fueled the cancer progression, including adhesion of non-senescent pEOCs to normal peritoneal cells, and their increased proliferation, migration, invasion, and EMT. Senescent pEOCs\u2019 secretome promoted angiogenic activity of vascular endothelium, induced senescence of normal peritoneal cells, reprogrammed their secretome towards hypersecretion of cancer-promoting proteins, and stimulated motility of cancer cells subjected to a mesothelium- and fibroblast-derived medium. The most striking finding was, however, that spontaneously senescent pEOCs supported all the above pro-cancerous effects more efficiently than drug-inducible senescent cells, which was plausibly related to augmented release of several cancer spread mediators by these cells. The prevalence of spontaneously senescent pEOCs was most evident in experiments on mice when they were able, unlike the drug-inducible cells, to promote the development of drug-sensitive i.p. xenografts.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Our study shows that spontaneous senescence of pEOCs should be treated as an independent pathogenetic factor of cancer progression.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13048-022-01023-y","type":"journal-article","created":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T08:02:52Z","timestamp":1658822572000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Pro-cancerogenic effects of spontaneous and drug-induced senescence of ovarian cancer cells in vitro and in vivo: a comparative analysis"],"prefix":"10.1186","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2194-6770","authenticated-orcid":false,"given":"Szymon","family":"Rutecki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5853-6380","authenticated-orcid":false,"given":"Paulina","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyna","family":"Paku\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6798-3043","authenticated-orcid":false,"given":"Pawe\u0142","family":"Uruski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8052-4418","authenticated-orcid":false,"given":"Artur","family":"Radziemski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eryk","family":"Naumowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5121-5026","authenticated-orcid":false,"given":"Rafa\u0142","family":"Moszy\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9786-6334","authenticated-orcid":false,"given":"Andrzej","family":"Tykarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8267-5428","authenticated-orcid":false,"given":"Justyna","family":"Miku\u0142a-Pietrasik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6066-5747","authenticated-orcid":false,"given":"Krzysztof","family":"Ksi\u0105\u017cek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,7,26]]},"reference":[{"issue":"4","key":"1023_CR1","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.cell.2005.02.003","volume":"120","author":"J Campisi","year":"2005","unstructured":"Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005;120(4):513\u201322.","journal-title":"Cell"},{"key":"1023_CR2","doi-asserted-by":"publisher","first-page":"722205","DOI":"10.3389\/fcell.2021.722205","volume":"9","author":"J Yang","year":"2021","unstructured":"Yang J, Liu M, Hong D, Zeng M, Zhang X. The paradoxical role of cellular senescence in cancer. Front Cell Dev Biol. 2021;9:722205.","journal-title":"Front Cell Dev Biol"},{"key":"1023_CR3","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1146\/annurev-pathol-121808-102144","volume":"5","author":"JP Coppe","year":"2010","unstructured":"Coppe JP, Desprez PY, Krtolica A, Campisi J. The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol. 2010;5:99\u2013118.","journal-title":"Annu Rev Pathol"},{"issue":"12","key":"1023_CR4","doi-asserted-by":"publisher","first-page":"e2565","DOI":"10.1038\/cddis.2016.417","volume":"7","author":"J Mikula-Pietrasik","year":"2016","unstructured":"Mikula-Pietrasik J, Uruski P, Sosinska P, Maksin K, Piotrowska-Kempisty H, Kucinska M, et al. Senescent peritoneal mesothelium creates a niche for ovarian cancer metastases. Cell Death Dis. 2016;7(12):e2565.","journal-title":"Cell Death Dis"},{"issue":"2","key":"1023_CR5","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00018-019-03261-8","volume":"77","author":"J Mikula-Pietrasik","year":"2020","unstructured":"Mikula-Pietrasik J, Niklas A, Uruski P, Tykarski A, Ksiazek K. Mechanisms and significance of therapy-induced and spontaneous senescence of cancer cells. Cell Mol Life Sci. 2020;77(2):213\u201329.","journal-title":"Cell Mol Life Sci"},{"issue":"4","key":"1023_CR6","doi-asserted-by":"publisher","first-page":"822","DOI":"10.3390\/cancers12040822","volume":"12","author":"T Saleh","year":"2020","unstructured":"Saleh T, Bloukh S, Carpenter VJ, Alwohoush E, Bakeer J, Darwish S, et al. Therapy-induced senescence: an \u201cold\u201d friend becomes the enemy. Cancers (Basel). 2020;12(4):822.","journal-title":"Cancers (Basel)"},{"issue":"6","key":"1023_CR7","first-page":"1876","volume":"62","author":"RH te Poele","year":"2002","unstructured":"te Poele RH, Okorokov AL, Jardine L, Cummings J, Joel SP. DNA damage is able to induce senescence in tumor cells in vitro and in vivo. Cancer Res. 2002;62(6):1876\u201383.","journal-title":"Cancer Res"},{"issue":"12","key":"1023_CR8","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1371\/journal.pbio.0060301","volume":"6","author":"JP Coppe","year":"2008","unstructured":"Coppe JP, Patil CK, Rodier F, Sun Y, Munoz DP, Goldstein J, et al. Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 2008;6(12):2853\u201368.","journal-title":"PLoS Biol"},{"issue":"3","key":"1023_CR9","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3322\/caac.20113","volume":"61","author":"D Jelovac","year":"2011","unstructured":"Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin. 2011;61(3):183\u2013203.","journal-title":"CA Cancer J Clin"},{"issue":"2","key":"1023_CR10","doi-asserted-by":"publisher","first-page":"296","DOI":"10.3390\/cancers12020296","volume":"12","author":"M Pakula","year":"2020","unstructured":"Pakula M, Maly E, Uruski P, Witucka A, Bogucka M, Jaroszewska N, et al. Deciphering the molecular mechanism of spontaneous senescence in primary epithelial ovarian cancer cells. Cancers (Basel). 2020;12(2):296.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"1023_CR11","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s11658-021-00287-4","volume":"26","author":"P Uruski","year":"2021","unstructured":"Uruski P, Sepetowska A, Konieczna C, Pakula M, Wyrwa M, Tussupkaliyev A, et al. Primary high-grade serous ovarian cancer cells are sensitive to senescence induced by carboplatin and paclitaxel in vitro. Cell Mol Biol Lett. 2021;26(1):44.","journal-title":"Cell Mol Biol Lett"},{"issue":"1","key":"1023_CR12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1586\/era.09.167","volume":"10","author":"C Marchetti","year":"2010","unstructured":"Marchetti C, Pisano C, Facchini G, Bruni GS, Magazzino FP, Losito S, et al. First-line treatment of advanced ovarian cancer: current research and perspectives. Expert Rev Anticancer Ther. 2010;10(1):47\u201360.","journal-title":"Expert Rev Anticancer Ther"},{"issue":"Suppl 14","key":"1023_CR13","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1186\/s12864-016-3352-4","volume":"17","author":"KC Kural","year":"2016","unstructured":"Kural KC, Tandon N, Skoblov M, Kel-Margoulis OV, Baranova AV. Pathways of aging: comparative analysis of gene signatures in replicative senescence and stress induced premature senescence. BMC Genomics. 2016;17(Suppl 14):1030.","journal-title":"BMC Genomics"},{"issue":"15","key":"1023_CR14","doi-asserted-by":"publisher","first-page":"2209","DOI":"10.1002\/elps.201300086","volume":"34","author":"GJ Aan","year":"2013","unstructured":"Aan GJ, Hairi HA, Makpol S, Rahman MA, Karsani SA. Differences in protein changes between stress-induced premature senescence and replicative senescence states. Electrophoresis. 2013;34(15):2209\u201317.","journal-title":"Electrophoresis"},{"issue":"1","key":"1023_CR15","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1007\/s10522-013-9477-9","volume":"15","author":"A Bielak-Zmijewska","year":"2014","unstructured":"Bielak-Zmijewska A, Wnuk M, Przybylska D, Grabowska W, Lewinska A, Alster O, et al. A comparison of replicative senescence and doxorubicin-induced premature senescence of vascular smooth muscle cells isolated from human aorta. Biogerontology. 2014;15(1):47\u201364.","journal-title":"Biogerontology"},{"issue":"3","key":"1023_CR16","first-page":"331","volume":"97","author":"K Jirsova","year":"1996","unstructured":"Jirsova K, Mandys V. Carboplatin-induced micronuclei formation in non-neuronal cells of rat foetal dorsal root ganglia cultured in vitro and comparison with another anticancer drug\u2013cisplatin. Sb Lek. 1996;97(3):331\u201342.","journal-title":"Sb Lek"},{"issue":"1","key":"1023_CR17","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.mrgentox.2004.01.013","volume":"560","author":"MT Branham","year":"2004","unstructured":"Branham MT, Nadin SB, Vargas-Roig LM, Ciocca DR. DNA damage induced by paclitaxel and DNA repair capability of peripheral blood lymphocytes as evaluated by the alkaline comet assay. Mutat Res. 2004;560(1):11\u20137.","journal-title":"Mutat Res"},{"key":"1023_CR18","doi-asserted-by":"crossref","unstructured":"von Zglinicki T, Saretzki G, Ladhoff J, d`Adda di Fagagna F, Jackson SP. Human cell senescence as a DNA damage response. Mech Ageing Dev. 2005;126(1):111\u20137.","DOI":"10.1016\/j.mad.2004.09.034"},{"issue":"2","key":"1023_CR19","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1016\/j.bbrc.2008.06.026","volume":"373","author":"K Ksiazek","year":"2008","unstructured":"Ksiazek K, Piatek K, Witowski J. Impaired response to oxidative stress in senescent cells may lead to accumulation of DNA damage in mesothelial cells from aged donors. Biochem Biophys Res Commun. 2008;373(2):335\u20139.","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"1023_CR20","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.exger.2007.04.012","volume":"42","author":"K Ksiazek","year":"2007","unstructured":"Ksiazek K, Winckiewicz M, Staniszewski R, Breborowicz A, Witowski J. Correlation between the donor age and the proliferative lifespan of human peritoneal mesothelial cells in vitro: is TGF-beta1 a link? Exp Gerontol. 2007;42(8):840\u20133.","journal-title":"Exp Gerontol"},{"issue":"21","key":"1023_CR21","doi-asserted-by":"publisher","first-page":"12072","DOI":"10.1073\/pnas.211053698","volume":"98","author":"A Krtolica","year":"2001","unstructured":"Krtolica A, Parrinello S, Lockett S, Desprez PY, Campisi J. Senescent fibroblasts promote epithelial cell growth and tumorigenesis: a link between cancer and aging. Proc Natl Acad Sci U S A. 2001;98(21):12072\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"1023_CR22","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1136\/mp.55.6.348","volume":"55","author":"ES Bamberger","year":"2002","unstructured":"Bamberger ES, Perrett CW. Angiogenesis in epithelian ovarian cancer. Mol Pathol. 2002;55(6):348\u201359.","journal-title":"Mol Pathol"},{"issue":"8","key":"1023_CR23","doi-asserted-by":"publisher","first-page":"e42436","DOI":"10.1371\/journal.pone.0042436","volume":"7","author":"JC Cheng","year":"2012","unstructured":"Cheng JC, Auersperg N, Leung PC. TGF-beta induces serous borderline ovarian tumor cell invasion by activating EMT but triggers apoptosis in low-grade serous ovarian carcinoma cells. PLoS ONE. 2012;7(8):e42436.","journal-title":"PLoS ONE"},{"issue":"16","key":"1023_CR24","doi-asserted-by":"publisher","first-page":"5016","DOI":"10.1158\/0008-5472.CAN-13-0023","volume":"73","author":"TL Yeung","year":"2013","unstructured":"Yeung TL, Leung CS, Wong KK, Samimi G, Thompson MS, Liu J, et al. TGF-beta modulates ovarian cancer invasion by upregulating CAF-derived versican in the tumor microenvironment. Cancer Res. 2013;73(16):5016\u201328.","journal-title":"Cancer Res"},{"issue":"2","key":"1023_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.cyto.2012.04.020","volume":"59","author":"Y Wang","year":"2012","unstructured":"Wang Y, Li L, Guo X, Jin X, Sun W, Zhang X, et al. Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells. Cytokine. 2012;59(2):228\u201336.","journal-title":"Cytokine"},{"issue":"5","key":"1023_CR26","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1007\/s13402-016-0289-1","volume":"39","author":"J Mikula-Pietrasik","year":"2016","unstructured":"Mikula-Pietrasik J, Uruski P, Matuszkiewicz K, Szubert S, Moszynski R, Szpurek D, et al. Ovarian cancer-derived ascitic fluids induce a senescence-dependent pro-cancerogenic phenotype in normal peritoneal mesothelial cells. Cell Oncol (Dordr ). 2016;39(5):473\u201381.","journal-title":"Cell Oncol (Dordr )"},{"issue":"12","key":"1023_CR27","first-page":"3367","volume":"12","author":"Y Wang","year":"2011","unstructured":"Wang Y, Hu C, Dong R, Huang X, Qiu H. Platelet-derived growth factor-D promotes ovarian cancer invasion by regulating matrix metalloproteinases 2 and 9. Asian Pac J Cancer Prev. 2011;12(12):3367\u201370.","journal-title":"Asian Pac J Cancer Prev"},{"issue":"3","key":"1023_CR28","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1016\/j.ygyno.2007.02.005","volume":"105","author":"T Baba","year":"2007","unstructured":"Baba T, Kariya M, Higuchi T, Mandai M, Matsumura N, Kondoh E, et al. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Gynecol Oncol. 2007;105(3):703\u201311.","journal-title":"Gynecol Oncol"},{"issue":"5\u20136","key":"1023_CR29","first-page":"247","volume":"22","author":"Q Guo","year":"2014","unstructured":"Guo Q, Gao BL, Zhang XJ, Liu GC, Xu F, Fan QY, et al. CXCL12-CXCR4 axis promotes proliferation, migration, invasion, and metastasis of ovarian cancer. Oncol Res. 2014;22(5\u20136):247\u201358.","journal-title":"Oncol Res"},{"issue":"1","key":"1023_CR30","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10585-015-9753-y","volume":"33","author":"J Mikula-Pietrasik","year":"2016","unstructured":"Mikula-Pietrasik J, Sosinska P, Naumowicz E, Maksin K, Piotrowska H, Wozniak A, et al. Senescent peritoneal mesothelium induces a pro-angiogenic phenotype in ovarian cancer cells in vitro and in a mouse xenograft model in vivo. Clin Exp Metastasis. 2016;33(1):15\u201327.","journal-title":"Clin Exp Metastasis"},{"key":"1023_CR31","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1016\/j.ebiom.2019.01.056","volume":"41","author":"S Short","year":"2019","unstructured":"Short S, Fielder E, Miwa S, von Zglinicki T. Senolytics and senostatics as adjuvant tumour therapy. EBioMedicine. 2019;41:683\u201392.","journal-title":"EBioMedicine"},{"issue":"17","key":"1023_CR32","doi-asserted-by":"publisher","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","volume":"21","author":"RF Ozols","year":"2003","unstructured":"Ozols RF, Bundy BN, Greer BE, Fowler JM, Clarke-Pearson D, Burger RA, et al. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. J Clin Oncol. 2003;21(17):3194\u2013200.","journal-title":"J Clin Oncol"},{"issue":"20","key":"1023_CR33","doi-asserted-by":"publisher","first-page":"9363","DOI":"10.1073\/pnas.92.20.9363","volume":"92","author":"GP Dimri","year":"1995","unstructured":"Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci U S A. 1995;92(20):9363\u20137.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1023_CR34","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.freeradbiomed.2017.06.015","volume":"110","author":"J Mikula-Pietrasik","year":"2017","unstructured":"Mikula-Pietrasik J, Uruski P, Pakula M, Maksin K, Szubert S, Wozniak A, et al. Oxidative stress contributes to hepatocyte growth factor-dependent pro-senescence activity of ovarian cancer cells. Free Radic Biol Med. 2017;110:270\u20139.","journal-title":"Free Radic Biol Med"},{"issue":"2","key":"1023_CR35","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.ab.2005.06.003","volume":"343","author":"RK Gary","year":"2005","unstructured":"Gary RK, Kindell SM. Quantitative assay of senescence-associated beta-galactosidase activity in mammalian cell extracts. Anal Biochem. 2005;343(2):329\u201334.","journal-title":"Anal Biochem"},{"issue":"11\u201312","key":"1023_CR36","doi-asserted-by":"publisher","first-page":"2234","DOI":"10.1016\/j.freeradbiomed.2012.03.014","volume":"52","author":"J Mikula-Pietrasik","year":"2012","unstructured":"Mikula-Pietrasik J, Kuczmarska A, Rubis B, Filas V, Murias M, Zielinski P, et al. Resveratrol delays replicative senescence of human mesothelial cells via mobilization of antioxidative and DNA repair mechanisms. Free Radic Biol Med. 2012;52(11\u201312):2234\u201345.","journal-title":"Free Radic Biol Med"},{"issue":"3","key":"1023_CR37","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1152\/japplphysiol.01086.2005","volume":"100","author":"K Ksiazek","year":"2006","unstructured":"Ksiazek K, Piwocka K, Brzezinska A, Sikora E, Zabel M, Breborowicz A, et al. Early loss of proliferative potential of human peritoneal mesothelial cells in culture: the role of p16INK4a-mediated premature senescence. J Appl Physiol. 2006;100(3):988\u201395.","journal-title":"J Appl Physiol"},{"issue":"8","key":"1023_CR38","doi-asserted-by":"publisher","first-page":"4222","DOI":"10.3390\/ijms22084222","volume":"22","author":"P Uruski","year":"2021","unstructured":"Uruski P, Mikula-Pietrasik J, Pakula M, Budkiewicz S, Drzewiecki M, Gaiday AN, et al. Malignant ascites promote adhesion of ovarian cancer cells to peritoneal mesothelium and fibroblasts. Int J Mol Sci. 2021;22(8):4222.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"1023_CR39","doi-asserted-by":"publisher","first-page":"7587","DOI":"10.1038\/s41598-019-44123-4","volume":"9","author":"M Pakula","year":"2019","unstructured":"Pakula M, Witucka A, Uruski P, Radziemski A, Moszynski R, Szpurek D, et al. Senescence-related deterioration of intercellular junctions in the peritoneal mesothelium promotes the transmesothelial invasion of ovarian cancer cells. Sci Rep. 2019;9(1):7587.","journal-title":"Sci Rep"},{"issue":"1","key":"1023_CR40","doi-asserted-by":"publisher","first-page":"137","DOI":"10.3390\/ijms20010137","volume":"20","author":"M Pakula","year":"2019","unstructured":"Pakula M, Mikula-Pietrasik J, Witucka A, Kostka-Jeziorny K, Uruski P, Moszynski R, et al. The epithelial-mesenchymal transition initiated by malignant ascites underlies the transmesothelial invasion of ovarian cancer cells. Int J Mol Sci. 2019;20(1):137.","journal-title":"Int J Mol Sci"}],"container-title":["Journal of Ovarian Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13048-022-01023-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13048-022-01023-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,26]],"date-time":"2022-07-26T08:06:13Z","timestamp":1658822773000},"score":1,"resource":{"primary":{"URL":"https:\/\/ovarianresearch.biomedcentral.com\/articles\/10.1186\/s13048-022-01023-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,26]]},"references-count":40,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["1023"],"URL":"https:\/\/doi.org\/10.1186\/s13048-022-01023-y","relation":{},"ISSN":["1757-2215"],"issn-type":[{"value":"1757-2215","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,26]]},"assertion":[{"value":"16 February 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 July 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The procedures involving human subjects (the isolation of tumors, omental tissues, and the cultivation of pEOCs, PMCs, and PFBs) were in accordance with the Helsinki Declaration of 1975. The study was approved by the Bioethics Committee at the Poznan University of Medical Sciences (resolution numbers: 543\/14, 299\/17 and 539\/21), and all the patients gave their informed consent. As per experiments on animals, they were carried out in accordance with the EU Directive 2010\/63\/EU and were approved by the Local Ethics Committee for Experiments on Animals (resolution number: 35\/2018).All the patients whose tissues were used in the study gave their written informed consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors have no relevant financial or non-financial interests to disclose.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"87"}}